Research advance of natural products in tumor immunotherapy
Open Access
- 2 September 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 972345
Abstract
Cancer immunotherapy has emerged as a novel anti-tumor treatment. Despite significant breakthroughs, cancer immunotherapy remains focused on several types of tumors that are sensitive to the immune system. Therefore, effective strategies to expand its indications and improve its efficacy become key factors for the further development of cancer immunotherapy. In recent decades, the anticancer activities of natural products are reported to have this effect on cancer immunotherapy. And the mechanism is largely attributed to the remodeling of the tumor immunosuppressive microenvironment. The compelling data highlight that natural products offer an alternative method option to improve immune function in the tumor microenvironment (TME). Currently, more attention is being paid to the discovery of new potential modulators of tumor immunotherapy from natural products. In this review, we describe current advances in employing natural products and natural small-molecule drugs targeting immune cells to avoid tumor immune escape, which may bring some insight for guiding tumor treatment.Keywords
This publication has 89 references indexed in Scilit:
- Increasing CCL5/CCR5 on CD4+ T cells in peripheral blood of oral lichen planusCytokine, 2013
- Macrophage plasticity and polarization: in vivo veritasJournal of Clinical Investigation, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseasesNature Reviews Immunology, 2010
- Aged garlic extract inhibits CD36 expression in human macrophages via modulation of the PPARγ pathwayPhytotherapy Research, 2010
- RETRACTED: Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkersBiochemical Pharmacology, 2010
- Resveratrol amelioratesSerratia marcescens-induced acute pneumonia in ratsJournal of Leukocyte Biology, 2008
- A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17Nature Immunology, 2005
- Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineagesNature Immunology, 2005
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002